These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2222551)
1. In vitro studies on interactions of iron salts and complexes with food-stuffs and medicaments. Geisser P Arzneimittelforschung; 1990 Jul; 40(7):754-60. PubMed ID: 2222551 [TBL] [Abstract][Full Text] [Related]
2. Spectrophotometric method for quantitative determination of iron (III) from iron polymaltose complex in pharmaceutical formulations. Hussain F; Arayne MS; Sultana N Pak J Pharm Sci; 2006 Oct; 19(4):299-303. PubMed ID: 17105708 [TBL] [Abstract][Full Text] [Related]
3. Iron pharmacokinetics after administration of ferric-hydroxide-polymaltose complex in rats. Geisser P; Müller A Arzneimittelforschung; 1984; 34(11):1560-9. PubMed ID: 6543131 [TBL] [Abstract][Full Text] [Related]
4. Interactions between iron(III)-hydroxide polymaltose complex and commonly used drugs / simulations and in vitro studies. Burckhardt-Herold S; Klotz J; Funk F; Büchi R; Petrig-Schaffland J; Geisser P Arzneimittelforschung; 2007; 57(6A):360-9. PubMed ID: 17691585 [TBL] [Abstract][Full Text] [Related]
5. Effect of oral aluminium hydroxide on iron absorption from iron(III)-hydroxide polymaltose complex in patients with iron deficiency anemia / a single-centre randomized controlled isotope study. Potgieter MA; Potgieter JH; Venter C; Venter JL; Geisser P Arzneimittelforschung; 2007; 57(6A):392-400. PubMed ID: 17691589 [TBL] [Abstract][Full Text] [Related]
6. [Preliminary studies on physicochemical properties of Angelica sinensis polysaccharide-iron complex]. Wang KP; Zhang Y; Dai LQ Zhongguo Zhong Yao Za Zhi; 2006 May; 31(9):747-50. PubMed ID: 17048684 [TBL] [Abstract][Full Text] [Related]
7. Interactions between iron(III)-hydroxide polymaltose complex and commonly used medications / laboratory studies in rats. Funk F; Canclini C; Geisser P Arzneimittelforschung; 2007; 57(6A):370-5. PubMed ID: 17691586 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of iron salts and ferric hydroxide-carbohydrate complexes. Geisser P; Müller A Arzneimittelforschung; 1987 Jan; 37(1A):100-4. PubMed ID: 3566862 [TBL] [Abstract][Full Text] [Related]
9. Effect of oral tetracycline on iron absorption from iron(III)-hydroxide polymaltose complex in patients with iron deficiency anemia / a single-centre randomized controlled isotope study. Potgieter MA; Potgieter JH; Venter C; Venter JL; Geisser P Arzneimittelforschung; 2007; 57(6A):376-84. PubMed ID: 17691587 [TBL] [Abstract][Full Text] [Related]
10. Chemical characterization of iron (III)-hydroxide-dextrin complexes. A comparative study of commercial preparations with alleged reproductions used in the examination of bioavailability. Erni I; Oswald N; Rich HW; Schneider W Arzneimittelforschung; 1984; 34(11):1555-9. PubMed ID: 6543130 [TBL] [Abstract][Full Text] [Related]
11. Iron polymaltose complexes: Could we spot physicochemical differences in medicines sharing the same active pharmaceutical ingredient? Di Francesco T; Delafontaine L; Philipp E; Lechat E; Borchard G Eur J Pharm Sci; 2020 Feb; 143():105180. PubMed ID: 31841697 [TBL] [Abstract][Full Text] [Related]
12. Effect of an oral iron(III)-hydroxide polymaltose complex on tetracycline pharmacokinetics in patients with iron deficiency anemia. Potgieter MA; Pretorius SG; Jacobs YL; Venter C; Venter JL; Geisser P Arzneimittelforschung; 2007; 57(6A):385-91. PubMed ID: 17691588 [TBL] [Abstract][Full Text] [Related]
13. Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations. Kaltwasser JP; Werner E; Niechzial M Arzneimittelforschung; 1987 Jan; 37(1A):122-9. PubMed ID: 3566867 [TBL] [Abstract][Full Text] [Related]
15. Spectrophotometric determination of ferric, ferrous, and total iron in drugs by reaction with alpha, alpha'-dipyridyl. Sullivan DJ J Assoc Off Anal Chem; 1976 Sep; 59(5):1156-61. PubMed ID: 965340 [TBL] [Abstract][Full Text] [Related]
16. Bioavailability of iron from oral ferric polymaltose in humans. Nielsen P; Gabbe EE; Fischer R; Heinrich HC Arzneimittelforschung; 1994 Jun; 44(6):743-8. PubMed ID: 8053973 [TBL] [Abstract][Full Text] [Related]
17. Intestinal absorption of 59Fe from neutron-activated commercial oral iron(III)-citrate and iron(III)-hydroxide-polymaltose complexes in man. Heinrich HC Arzneimittelforschung; 1987 Jan; 37(1A):105-7. PubMed ID: 3566863 [TBL] [Abstract][Full Text] [Related]
18. Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose. Jacobs P; Johnson G; Wood L J Med; 1984; 15(5-6):367-77. PubMed ID: 6599114 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of iron(III)-hydroxide polymaltose complex / a review of over 25 years experience. Geisser P Arzneimittelforschung; 2007; 57(6A):439-52. PubMed ID: 17691594 [TBL] [Abstract][Full Text] [Related]
20. Determination of iron in drugs. Verma KK; Gupta AK; Bose S Farmaco Prat; 1981 Jan; 36(1):23-9. PubMed ID: 7227492 [No Abstract] [Full Text] [Related] [Next] [New Search]